Morpholino

MO2-gldc

ID
ZDB-MRPHLNO-240219-12
Name
MO2-gldc
Previous Names
None
Target
Sequence
5' - CTGAGAGACTGACTGAAATAACCAG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-gldc
No data available
Phenotype
Phenotype resulting from MO2-gldc
No data available
Phenotype of all Fish created by or utilizing MO2-gldc
Phenotype Fish Conditions Figures
whole organism viability, abnormal WT + MO1-gldc + MO2-gldc control Figure 1 with image from Weaver et al., 2022
pericardium edematous, abnormal WT + MO1-gldc + MO2-gldc control Figure 1 with image from Weaver et al., 2022
cloaca pax2a expression increased distribution, abnormal WT + MO1-gldc + MO2-gldc control Figure 5 with image from Weaver et al., 2022
pronephric proximal convoluted tubule slc20a1a expression decreased distribution, abnormal WT + MO1-gldc + MO2-gldc control Figure 3 with image from Weaver et al., 2022
cloaca gata3 expression increased distribution, abnormal WT + MO1-gldc + MO2-gldc control Figure 5 with image from Weaver et al., 2022
pronephric distal early tubule irx1a expression increased distribution, abnormal WT + MO1-gldc + MO2-gldc control Figure 4 with image from Weaver et al., 2022
pronephric distal late tubule tbx2b expression decreased distribution, abnormal WT + MO1-gldc + MO2-gldc control Figure 4 with image from Weaver et al., 2022
migratory cranial neural crest dlx2a expression spatial pattern, abnormal WT + MO1-gldc + MO2-gldc control Figure 2 with image from Weaver et al., 2022
cloaca apoptotic process increased process quality, abnormal WT + MO1-gldc + MO2-gldc control Figure 5 with image from Weaver et al., 2022
brain apoptotic process increased process quality, abnormal WT + MO1-gldc + MO2-gldc control Figure 2 with image from Weaver et al., 2022
pronephric distal early tubule irx3b expression increased distribution, abnormal WT + MO1-gldc + MO2-gldc control Figure 4 with image from Weaver et al., 2022
Meckel's cartilage morphology, abnormal WT + MO1-gldc + MO2-gldc control Figure 1 with image from Weaver et al., 2022
pronephric distal late tubule tbx2a expression decreased distribution, abnormal WT + MO1-gldc + MO2-gldc control Figure 4 with image from Weaver et al., 2022
cloaca increased area, abnormal WT + MO1-gldc + MO2-gldc control Figure 5 with image from Weaver et al., 2022
pronephric proximal straight tubule multi-ciliated epithelial cell cimap1b expression increased distribution, abnormal WT + MO1-gldc + MO2-gldc control Figure 3 with image from Weaver et al., 2022
pharyngeal arch decreased amount, abnormal WT + MO1-gldc + MO2-gldc control Figure 1 with image from Weaver et al., 2022
ventricular system swollen, abnormal WT + MO1-gldc + MO2-gldc control Figure 1 with image from Weaver et al., 2022
rhombomere 3 egr2b expression spatial pattern, abnormal WT + MO1-gldc + MO2-gldc control Figure 2 with image from Weaver et al., 2022
pronephric distal late tubule slc12a3 expression decreased distribution, abnormal WT + MO1-gldc + MO2-gldc control Figure 3 with imageFigure 6 with image from Weaver et al., 2022
pronephric distal late tubule mecom expression decreased distribution, abnormal WT + MO1-gldc + MO2-gldc control Figure 4 with image from Weaver et al., 2022
pronephric distal early tubule slc12a1 expression increased distribution, abnormal WT + MO1-gldc + MO2-gldc control Figure 3 with imageFigure 6 with image from Weaver et al., 2022
pronephros apoptotic process increased process quality, abnormal WT + MO1-gldc + MO2-gldc control Figure 2 with image from Weaver et al., 2022
renal filtration decreased process quality, abnormal WT + MO1-gldc + MO2-gldc control Figure 3 with image from Weaver et al., 2022
cloaca cell aggregated, abnormal WT + MO1-gldc + MO2-gldc control Figure 5 with image from Weaver et al., 2022
cloaca mecom expression increased distribution, abnormal WT + MO1-gldc + MO2-gldc control Figure 5 with image from Weaver et al., 2022
ventricular system increased volume, abnormal WT + MO1-gldc + MO2-gldc control Figure 2 with image from Weaver et al., 2022
rhombomere mecom expression spatial pattern, abnormal WT + MO1-gldc + MO2-gldc control Figure 2 with image from Weaver et al., 2022
head necrotic, abnormal WT + MO1-gldc + MO2-gldc control Figure 1 with image from Weaver et al., 2022
Citations